BiotechTV - News

ASCO 2025: Legend Biotech's CEO Ying Huang discusses new CARVYKTI data at ASCO as well as early stage data for emerging CAR-T targets against solid tumors

Jun 2, 2025
Ask episode
Chapters
Transcript
Episode notes